Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma

Fig. 3

Comparison of relative miR-197 expression levels and frequency of patients with progression in the GCB, non-GCB/miR-197low and non-GCB/miR-197high subgroups of diffuse large B-cell lymphoma. Compared with the GCB and non-GCB/miR-197high subgroups exhibiting similar levels of miR-197 expression, the non-GCB/miR-197low subgroup exhibited low miR-197 levels and high progression rates in full cohort (a) and R-CHOP cohort (b)

Back to article page